Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Ann Neurol Retrieve available abstracts of 30 articles: HTML format

Single Articles

June 2025
1. MILA-ALOMA M, Tosun D, Schindler SE, Hausle I, et al
   Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
   Ann Neurol. 2025 Jun 20. doi: 10.1002/ana.27285.
   PubMed     Abstract available
   
   
   
2. IAZZOLINO B, Palumbo F, Moglia C, Manera U, et al
   Frequency and Early Predictors of Cognitive Deterioration in Amyotrophic Lateral Sclerosis: A Longitudinal Population-Based Study.
   Ann Neurol. 2025;97:1122-1133.
   PubMed     Abstract available
   
   
   May 2025
3. BRAUN AS, Satoh R, Pham NTT, Singh-Reilly N, et al
   Machine Learning Models of Voxel-Level [(18)F] Fluorodeoxyglucose Positron Emission Tomography Data Excel at Predicting Progressive Supranuclear Palsy Pathology.
   Ann Neurol. 2025 May 30. doi: 10.1002/ana.27265.
   PubMed     Abstract available
   
   
   April 2025
4. LUO C, Nguyen TN, Li R, Tao C, et al
   Computed Tomography Perfusion Parameters: A Potential Tool for Treatment Selection in Basilar Artery Occlusion.
   Ann Neurol. 2025 Apr 2. doi: 10.1002/ana.27214.
   PubMed     Abstract available
   
   
   
5. BROWN EG, Chahine LM, Siderowf A, Gochanour C, et al
   Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
   Ann Neurol. 2025;97:730-740.
   PubMed     Abstract available
   
   
   March 2025
6. DZIALAS V, Bischof GN, Mollenhoff K, Drzezga A, et al
   Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease.
   Ann Neurol. 2025 Mar 27. doi: 10.1002/ana.27223.
   PubMed     Abstract available
   
   
   
7. LAGARDE J, Maiti P, Schonhaut DR, Blazhenets G, et al
   Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
   Ann Neurol. 2025 Mar 17. doi: 10.1002/ana.27233.
   PubMed     Abstract available
   
   
   
8. ARRIOLA-INFANTE JE, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, et al
   Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome.
   Ann Neurol. 2025 Mar 14. doi: 10.1002/ana.27226.
   PubMed     Abstract available
   
   
   February 2025
9. CANOSA A, Manera U, Vasta R, Zocco G, et al
   Brain Metabolic Features of FUS-ALS: A 2-[(18)F]FDG-PET Study.
   Ann Neurol. 2025 Feb 20. doi: 10.1002/ana.27201.
   PubMed     Abstract available
   
   
   
10. KEUM M, Byun MS, Yi D, Ahn H, et al
    The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology.
    Ann Neurol. 2025 Feb 17. doi: 10.1002/ana.27204.
    PubMed     Abstract available
    
    
    January 2025
11. LI J, Chen D, Tang Y, Chen Z, et al
    Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through [(18)F]SynVesT-1 PET Imaging.
    Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27179.
    PubMed     Abstract available
    
    
    December 2024
12. KIM N, Ryu WS, Ha SY, Kim JY, et al
    Optimal Cerebral Blood Flow Thresholds for Ischemic Core Estimation Using Computed Tomography Perfusion and Diffusion-Weighted Imaging.
    Ann Neurol. 2024 Dec 26. doi: 10.1002/ana.27169.
    PubMed     Abstract available
    
    
    
13. BRIER MR, Judge B, Ying C, Salter A, et al
    Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
    Ann Neurol. 2024 Dec 23. doi: 10.1002/ana.27165.
    PubMed     Abstract available
    
    
    October 2024
14. ENGELS-DOMINGUEZ N, Riphagen JM, Van Egroo M, Koops EA, et al
    Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals.
    Ann Neurol. 2024;96:650-661.
    PubMed     Abstract available
    
    
    September 2024
15. MUTIMER CA, Mujanovic A, Kaesmacher J, Churilov L, et al
    Comparison of Perfusion Imaging Definitions of the No-Reflow Phenomenon after Thrombectomy-What Is the Best Perfusion Imaging Definition?
    Ann Neurol. 2024 Sep 3. doi: 10.1002/ana.27073.
    PubMed     Abstract available
    
    
    
16. BRUMBERG J, Blazhenets G, Buhler S, Fostitsch J, et al
    Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Ann Neurol. 2024;96:539-550.
    PubMed     Abstract available
    
    
    August 2024
17. BITZER F, Walger L, Bauer T, Schulte F, et al
    Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography Framework.
    Ann Neurol. 2024 Aug 21. doi: 10.1002/ana.27061.
    PubMed     Abstract available
    
    
    
18. HIRATA K, Matsuoka K, Tagai K, Endo H, et al
    In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
    Ann Neurol. 2024;96:247-261.
    PubMed     Abstract available
    
    
    June 2024
19. SOLEIMANI-MEIGOONI DN, Smith R, Provost K, Lesman-Segev OH, et al
    Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
    Ann Neurol. 2024 Jun 18. doi: 10.1002/ana.27008.
    PubMed     Abstract available
    
    
    May 2024
20. SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al
    Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
    Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957.
    PubMed     Abstract available
    
    
    
21. LAN G, Chen X, Yang J, Sun P, et al
    Microglial Reactivity Correlates with Presynaptic Loss Independent of beta-Amyloid and Tau.
    Ann Neurol. 2024;95:917-928.
    PubMed     Abstract available
    
    
    April 2024
22. GARCIA-CORDERO I, Anastassiadis C, Khoja A, Morales-Rivero A, et al
    Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
    Ann Neurol. 2024 Apr 5. doi: 10.1002/ana.26930.
    PubMed     Abstract available
    
    
    March 2024
23. ARNALDI D, Mattioli P, Raffa S, Pardini M, et al
    Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
    Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902.
    PubMed     Abstract available
    
    
    
24. PAPP KV, Jutten RJ, Soberanes D, Weizenbaum E, et al
    Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.
    Ann Neurol. 2024;95:507-517.
    PubMed     Abstract available
    
    
    February 2024
25. LI Y, Yen D, Hendrix RD, Gordon BA, et al
    Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
    Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26891.
    PubMed     Abstract available
    
    
    
26. CHEN X, Toueg TN, Harrison TM, Baker SL, et al
    Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Ann Neurol. 2024;95:249-259.
    PubMed     Abstract available
    
    
    December 2023
27. BONOMI S, Lu R, Schindler SE, Bui Q, et al
    Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
    Ann Neurol. 2023 Dec 1. doi: 10.1002/ana.26838.
    PubMed     Abstract available
    
    
    November 2023
28. CHUN MY, Chung SJ, Kim SH, Park CW, et al
    Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early-Phase (18) F-FP-CIT PET Study.
    Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827.
    PubMed     Abstract available
    
    
    October 2023
29. ZHENG L, Rubinski A, Dennecke J, Luan Y, et al
    Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer's Disease.
    Ann Neurol. 2023 Oct 14. doi: 10.1002/ana.26818.
    PubMed     Abstract available
    
    
    July 2023
30. PISANI L, Haussen DC, Mohammaden M, Perry da Camara C, et al
    Comparison of CT Perfusion Software Packages for Thrombectomy Eligibility.
    Ann Neurol. 2023 Jul 25. doi: 10.1002/ana.26748.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.